ノースダコタにおける頭頸部扁平上皮癌の臨床試験
ノースダコタ内の拠点で、頭頸部扁平上皮癌に関する6件の研究が参加者を募集しています。
ノースダコタ内の都市
公式研究テキスト（英語）
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
- Sanford Bismarck Medical Center, Bismarck
- Sanford Broadway Medical Center, Fargo
- Sanford Roger Maris Cancer Center, Fargo
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/02更新 · NCT06992427Testing the Addition of Anti-Cancer Drug, Cetuximab, to Standard of Care Treatment (Pembrolizumab) for Returning or Spreading Head and Neck Cancer After Previous Treatment
- Sanford Bismarck Medical Center, Bismarck
- Sanford Broadway Medical Center, Fargo
- Sanford Roger Maris Cancer Center, Fargo
被験者募集中第3相
18歳以上 · 全性別 · 2026/10/01更新 · NCT06589804BiCaZO: A Study Combining Two Immunotherapies (Cabozantinib and Nivolumab) to Treat Patients With Advanced Melanoma or Squamous Cell Head and Neck Cancer, an immunoMATCH Pilot Study
- Sanford Bismarck Medical Center, Bismarck
- Essentia Health Cancer Center-South University Clinic, Fargo
- Sanford Broadway Medical Center, Fargo
- 他2件
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/25更新 · NCT05136196Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma
- Sanford Bismarck Medical Center, Bismarck
- Sanford Roger Maris Cancer Center, Fargo
被験者募集中第2相
18歳〜79歳 · 全性別 · 2026/09/22更新 · NCT04671667Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery
- Sanford Bismarck Medical Center, Bismarck
- Essentia Health Cancer Center-South University Clinic, Fargo
- Sanford South University Medical Center, Fargo
- 他3件
被験者募集中第2相
18歳以上 · 全性別 · 2026/09/14更新 · NCT02734537A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
- Sanford Fargo, Fargo
被験者募集中観察研究
18歳以上 · 全性別 · 2026/09/03更新 · NCT06163534ClinicalTrials.govより、2026/10/06時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。